These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 6262150

  • 1. Herd effect and virus eradication with use of killed poliovirus vaccine.
    Salk D.
    Dev Biol Stand; 1981; 47():247-55. PubMed ID: 6262150
    [Abstract] [Full Text] [Related]

  • 2. Anomalous observations on IPV and OPV vaccination.
    John TJ.
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [Abstract] [Full Text] [Related]

  • 3. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J.
    Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
    [Abstract] [Full Text] [Related]

  • 4. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC, Modlin JF.
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [Abstract] [Full Text] [Related]

  • 5. [Worldwide eradication of poliomyelitis].
    Rasch G, Schreier E, Kiehl W, Kurth R.
    Wien Klin Wochenschr; 2001 Oct 30; 113(20-21):839-45. PubMed ID: 11732120
    [Abstract] [Full Text] [Related]

  • 6. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ.
    Bull World Health Organ; 2004 Jan 30; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [Abstract] [Full Text] [Related]

  • 7. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
    Băicuş A, Persu A, Combiescu M, Aubert-Combiescu A.
    Roum Arch Microbiol Immunol; 2007 Jan 30; 66(1-2):44-50. PubMed ID: 18928063
    [Abstract] [Full Text] [Related]

  • 8. Poliomyelitis vaccination benefits--versus risk.
    Assaad F.
    Dev Biol Stand; 1979 Jan 30; 43():141-50. PubMed ID: 520666
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. World wide experience with inactivated poliovirus vaccine.
    Bonnet MC, Dutta A.
    Vaccine; 2008 Sep 15; 26(39):4978-83. PubMed ID: 18680777
    [Abstract] [Full Text] [Related]

  • 11. The spread of wild poliovirus in the well-vaccinated Netherlands in connection with the 1978 epidemic.
    Schaap GJ, Bijkerk H, Coutinho RA, Kapsenberg JG, van Wezel AL.
    Prog Med Virol; 1984 Sep 15; 29():124-40. PubMed ID: 6322230
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Epidemiology of poliomyelitis--options and update.
    Dutta A.
    Vaccine; 2008 Oct 23; 26(45):5767-73. PubMed ID: 18755232
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Criteria for control of infectious diseases with poliomyelitis as an example.
    Evans AS.
    Prog Med Virol; 1984 Oct 23; 29():141-65. PubMed ID: 6322231
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Poliomyelitis in The Netherlands, 1979-1991: immunity and exposure].
    Rümke HC, Oostvogel PM, van der Veer M, van Steenis G, van Loon AM.
    Ned Tijdschr Geneeskd; 1993 Jul 10; 137(28):1380-6. PubMed ID: 8240513
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Polio endgame. Polio: The final assault?
    Roberts L.
    Science; 2004 Mar 26; 303(5666):1960-8. PubMed ID: 15044779
    [No Abstract] [Full Text] [Related]

  • 20. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
    Abbink F, Buisman AM, Doornbos G, Woldman J, Kimman TG, Conyn-van Spaendonck MA.
    J Infect Dis; 2005 Mar 15; 191(6):990-9. PubMed ID: 15717277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.